To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

June 30, 2001

Conditions
Schizoaffective DisorderSchizophrenia
Interventions
DRUG

Haloperidol

DRUG

Olanzapine

Trial Locations (18)

10010

New York Harbor HCS, New York

10548

Franklin Delano Roosevelt Campus, VA Hudson Valley HCS, Montrose

15240

VA Pittsburgh Health Care System, Pittsburgh

19104

VA Medical Center, Philadelphia, Philadelphia

21902

VA Maryland HCS, Perry Point Division, Perry Point

27705

VA Medical Center, Durham, Durham

30904

VA Medical Center, Augusta, Augusta

33125

VA Medical Center, Miami, Miami

33708

VA Medical Center, Bay Pines, Bay Pines

35404

VA Medical Center, Tuscaloosa, Tuscaloosa

44106

VA Medical Center, Cleveland, Cleveland

48201

John D. Dingell VA Medical Center, Detroit, Detroit

94304-1290

VA Palo Alto Health Care System, Palo Alto

06516

VA Connecticut Health Care System (West Haven), West Haven

46202-2884

Richard Roudebush VA Medical Center, Indianapolis, Indianapolis

01730

Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Bedford

07018

VA New Jersey Health Care System, East Orange, East Orange

87108-5153

New Mexico VA Health Care System, Albuquerque, Albuquerque

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

US Department of Veterans Affairs

FED

NCT00007774 - To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter